A coil in the applicator makes a rapidly pulsed magnetic field. The field passes through clothing, skin and fat without being felt as current. It sets up an electrical current in the tissue underneath. That current then acts on motor nerves directly.
This is why the feeling has no everyday equal: A voluntary contraction is limited by how many motor units your nervous system calls on, and how fast it can fire them. A contraction triggered at the nerve goes past that limit. That is what the word supramaximal means here. The muscle goes rigid, holds, and lets go on the machine's schedule rather than yours.
Most people describe it as strong pulling or cramping without pain, in a muscle they cannot let go of. Between the strong phases, the machine runs slower tapping phases. Clinics often call that a lactic acid flush. The phrase is clinic language, not a measured process.
Treatment does not start at full intensity. The operator begins low. Over the first several minutes they raise the setting, checking what you can take.
So the dose is partly your decision, and that has two consequences: The first is practical. If it is genuinely too much, say so and the setting comes down. Nothing about the session requires you to hold still through pain. The second is about reading results. The published trials set the active groups to the highest level people could stand. A session run at a comfortable middle setting is not the treatment those studies measured. No study has compared outcomes at different intensities.
The most usable comfort numbers sit in FDA's own summaries of the maker's trials. They are given as counts rather than adjectives.
Abdomen, EmSculpt NEO, 42 people completing: 92.9 per cent reported none to minimal discomfort.
Thighs, EmSculpt NEO, 29 people: On a 0 to 10 pain scale, 19 scored 0 and 10 reported weak pain. Every participant agreed or strongly agreed that the treatment was comfortable.
Upper arms, EmSculpt NEO, 40 people: 33 reported no pain and 7 reported weak pain.
A published upper-arm study of 34 people enrolled reported a visual analogue pain score of 1.58 plus or minus 2.0, with comfort rated by 91 per cent.
A 33-person abdominal ultrasound study of EmSculpt alone reported simply: "No discomfort was reported."
Read these knowing who produced them: These are the maker's own trials, and the wider literature has the same signature. One review of seven EmSculpt NEO studies states that all seven were written by BTL medical advisors. Another covered 14 electromagnetic body-contouring studies. It states that almost all were written by medical advisors to the device maker. Comfort is a subjective endpoint, collected by the people running the study. That is exactly the kind of endpoint an affiliation moves.
EmSculpt NEO adds radiofrequency to the magnetic field. So there is a warming feeling on top of the contraction. Clinics compare it to a hot stone massage.
Two different temperatures appear in the FDA record. That is not a contradiction. It reflects two different claims: On the fat-reduction filing, the performance testing states that "the therapy temperature of 40 – 43 °C was achieved and maintained for the remaining therapy time". On the muscle-claim filing, the radiofrequency does something smaller: "The radiofrequency is warming the applicators' surface to below 40 °C thus enhancing the patient's comfort during the treatment."
The maker's trade-press material gives higher figures still. It has fat heated to 43 to 45 degrees and muscle to 40 to 41 degrees. Those are marketing figures, and they sit above what the FDA file states. Where the two disagree, the FDA record is the better source.
In practice, this is the part people find harder to place. It is a deep warmth. It builds over the first few minutes and stays for the rest of the session, while the contractions carry on underneath.
Expect soreness like the day after unfamiliar exercise, not like recovery from a procedure: In the 42-person NEO abdominal study, 11 people reported muscle soreness after treatment. A separate 27-person study published in 2026 found short-lived muscle soreness in 29.6 per cent. It called that the most common side effect. Its authors state the study was designed and analysed independently of a sponsor they do not name.
No published protocol builds in any downtime. There is no anaesthetic, no numbing cream, no dressing, and no rule about driving or working. One person in the NEO abdominal study had mild redness of the skin.
Most published studies of both devices report no adverse events at all. Two independent reviews of the field reach the same conclusion on safety. Their author is otherwise strongly critical of the evidence that these devices work. He writes: "Electromagnetic treatments, either administered alone or in combination with radiofrequency, are safe."
FDA's device experience database, MAUDE, collects reports of problems after devices are on the market. Reporting is voluntary, and the database has no denominator. There is no way to know how many treatments were given. So these counts can never be turned into a chance that something happens to you.
A search of that database for this manufacturer returns 31 reports across all its products and all years. Six of those name EmSculpt or EmSculpt NEO.
One burn: A 2022 report describes an EmSculpt NEO treatment that "caused burn to skin (mid suprapubic with a 2 cm open erosion of the skin)". The bottom of the applicator was resting on the burned area. The same report describes a suspected abdominal haematoma, with extreme tenderness, that took about ten weeks to settle.
One firm lump: A 2023 report describes hard lumps on each quadriceps where the applicator had been placed.
Three menstrual or ovarian complaints filed by patients between 2019 and 2021. No causal link was established in any of them, and one reporter noted "perhaps it is a coincidence".
One commercial complaint from a purchaser about sales claims rather than a patient injury.
Six reports is a small number, and it is also not a safety record. It tells you which kinds of events have been reported at all, not how often they occur.
For most treatments you can read what the maker tells the operator. BTL does not publish its instructions for use for EmSculpt or EmSculpt NEO, and FDA does not publish them either. The Indications for Use statements that FDA does publish say nothing about comfort, nothing about intensity, and nothing about how to space sessions.
So there is no labelled answer to "how much should this hurt". There is no labelled contraindication list from the maker to check yourself against either. What does exist is the openly published safety information for CoolTone. CoolTone is an Allergan magnetic muscle stimulator, cleared in the same product code. That is another company's document for another device. It is not EmSculpt's labelling. But it is the closest published statement of what this class of device rules out, and its logic follows from the physics rather than from the brand.
Say in advance if you have any implanted electronic or metal device: Pacemakers, implanted defibrillators, neurostimulators, drug pumps and implanted hearing devices are contraindications across this class. An induced current does not tell muscle and metal apart. FDA's consumer page on electronic muscle stimulators warns about pacemakers and implants by name. The CoolTone safety document lists them as contraindications for a same-class device.
Also raise, before the appointment rather than on the day:
A hernia in or near the treatment area, including an umbilical hernia or a repaired one. Forced contraction over a gap in the abdominal wall is the concern. FDA names hernia in the risk list for this whole treatment category.
A seizure disorder or epilepsy.
A bleeding disorder, or blood-thinning medication.
Metalwork in the field: Plates, screws, joint replacements, coils, an intrauterine device.
A cancer diagnosis involving tissue in the treatment area.
Recent surgery in the area.
Numb skin in the area: You cannot report a feeling you do not have, and the intensity is set by what you report.
Fever with spreading redness, warmth or pus from a burned or broken area of skin. These are signs of a spreading infection and need urgent care the same day.
Chest pain, palpitations, fainting or a change you can feel in an implanted cardiac device during or after treatment.
A blister, burn or open area appears where the applicator sat
Pain increases after about day three instead of settling
Bruising or extreme tenderness develops over the treated area
A firm lump appears where the applicator was placed and does not resolve
Soreness stops you moving normally, rather than just reminding you it is there
Numbness or altered sensation in the area persists beyond a few days